These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8192688)

  • 1. Nicotine dependence--mechanisms and therapeutic strategies.
    Clarke PB
    Biochem Soc Symp; 1993; 59():83-95. PubMed ID: 8192688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nicotine dependence].
    Lebargy F
    Rev Pneumol Clin; 2000 Jun; 56(3):177-83. PubMed ID: 10880944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropharmacology of smoking: basic research opens new therapeutic possibilities].
    Svensson TH; Grenhoff J
    Lakartidningen; 1991 May; 88(22):2066-71. PubMed ID: 2051876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of nicotine conditioning by dopamine D(3) receptor ligands.
    Le Foll B; Schwartz JC; Sokoloff P
    Mol Psychiatry; 2003 Feb; 8(2):225-30. PubMed ID: 12610655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
    Rollema H; Coe JW; Chambers LK; Hurst RS; Stahl SM; Williams KE
    Trends Pharmacol Sci; 2007 Jul; 28(7):316-25. PubMed ID: 17573127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiology of nicotine addiction: implications for smoking cessation treatment.
    Benowitz NL
    Am J Med; 2008 Apr; 121(4 Suppl 1):S3-10. PubMed ID: 18342164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
    Rose JE; Herskovic JE; Behm FM; Westman EC
    Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New drugs; varenicline].
    van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does bupropion work as a smoking cessation aid?
    Warner C; Shoaib M
    Addict Biol; 2005 Sep; 10(3):219-31. PubMed ID: 16109583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural mechanisms underlying nicotine dependence.
    Balfour DJ
    Addiction; 1994 Nov; 89(11):1419-23. PubMed ID: 7841851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of antiaddictive actions of ibogaine.
    Glick SD; Maisonneuve IS
    Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E; Piekoszewski W
    Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies.
    Oliver JL; Pashmi G; Barnett P; Mettens P; Biemans R; Monteyne P; Palmantier R; Gallagher T; Ramaya S; Wonnacott S
    Vaccine; 2007 Oct; 25(42):7354-62. PubMed ID: 17870213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
    Foulds J
    Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking kills (alcoholics)! shouldn't we do something about it?
    Littleton J; Barron S; Prendergast M; Nixon SJ
    Alcohol Alcohol; 2007; 42(3):167-73. PubMed ID: 17526626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nicotine acetylcholine receptors and neuropsychiatric disorders].
    Vázquez-Palacios G; Bonilla-Jaime H
    Rev Neurol; 2004 Dec 16-31; 39(12):1146-60. PubMed ID: 15625635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.